Updated REMS for Rosiglitazone-containing Medicines

Published Online: Friday, October 21, 2011
Follow Pharmacy_Times:
Listen as Catherine Chew, a pharmacist in the FDA’s Division of Drug Information, describes the restrictions for prescribing and using rosiglitazone-containing medicines, including type 2 diabetes medications Avandia, Avandamet, and Avandaryl.

Click here to access the podcast.
Related Articles
Xigduo XR combines 2 anti-hyperglycemic agents with complementary mechanisms of action.
B. Douglas Hoey, RPh, MBA, CEO of the National Community Pharmacists Association (NCPA), discusses increasing generic drug prices and the problems they create for independent community pharmacists.
Latest Issues
$auto_registration$